HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC P/CF

The P/CF (Price-to-Cash-Flow Ratio) of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 224.16. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 23.14 — a change of 868.56% (higher).

P/CF

224.16

YoY

868.56%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of HaTay Pharmaceutical JSC is 2024 224.16 . P/CF (Price-to-Cash-Flow Ratio) of HaTay Pharmaceutical JSC was 2023 23.14 . It decreases by 868.56% higher compared to the previous year.

The HaTay Pharmaceutical JSC P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2017
2,114.28 VND
Jan 1, 2018
68.38 VND
Jan 1, 2019
58.49 VND
Jan 1, 2020
66.19 VND
Jan 1, 2021
-269.06 VND
Jan 1, 2022
-158.78 VND
Jan 1, 2023
23.14 VND
Jan 1, 2024
224.16 VND
The HaTay Pharmaceutical JSC P/CF history
YEARP/CFYoY
224.16+868.56%
23.14-114.58%
-158.78-40.99%
-269.06-506.53%
66.19+13.16%
58.49-14.46%
68.38-96.77%
2,114.28+1,432.57%
137.96-135.02%
-393.96-135.24%
1,117.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

P/CF (Price-to-Cash-Flow Ratio) of HaTay Pharmaceutical JSC is 224.16 in 2024.

P/CF (Price-to-Cash-Flow Ratio) of HaTay Pharmaceutical JSC changed from 23.14 to 224.16, representing a 868.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — HaTay Pharmaceutical JSC

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — HaTay Pharmaceutical JSC